T-705 (favipiravir) activity against lethal H5N1 influenza A viruses

T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections

(2009) Yousuke Furuta et al.   ANTIVIRAL RESEARCH

Intracellular metabolism of favipiravir (T-705) in uninfected and influenza A (H5N1) virus-infected cells

(2009) D. F. Smee et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Selection of H5N1 Influenza Virus PB2 during Replication in Humans

(2009) Q. M. Le et al.   JOURNAL OF VIROLOGY

Activity of T-705 in a Hamster Model of Yellow Fever Virus Infection in Comparison with That of a Chemically Related Compound, T-1106

(2008) J. G. Julander et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Efficacy of orally administered T-705 pyrazine analog on lethal West Nile virus infection in rodents

(2008) J MORREY et al.   ANTIVIRAL RESEARCH

The potential impact of neuraminidase inhibitor resistant influenza

(2008) Angie Lackenby et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Treatment of Late Stage Disease in a Model of Arenaviral Hemorrhagic Fever: T-705 Efficacy and Reduced Toxicity Suggests an Alternative to Ribavirin

(2008) Brian B. Gowen et al.   PLoS One

Injectable peramivir mitigates disease and promotes survival in ferrets and mice infected with the highly virulent influenza virus, A/Vietnam/1203/04 (H5N1)

(2008) Nadezhda E. Yun et al.   VIROLOGY

Amantadine-resistance among H5N1 avian influenza viruses isolated in Northern China

(2007) Guimei He et al.   ANTIVIRAL RESEARCH